Expression of inositol trisphosphate receptors

Cell Calcium

Volumn 26, Issue 6, 1999, Pages 237-251

  Taylor, C W ^a   Genazzani, A A ^a   Morris, S A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; INOSITOL TRISPHOSPHATE; MESSENGER RNA; RECEPTOR; RECEPTOR SUBTYPE;

BINDING SITE; CALCIUM TRANSPORT; CELL MEMBRANE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION REGULATION;

EID: 0033378368     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1054/ceca.1999.0090     Document Type: Review

References (145)

1. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
2. 2+. J Gen Physiol. 108:1996;115-124.
3. Supattapone S., Worley P. F., Baraban J. M., Snyder S. H. Solubilization, purification, and characterization of an inositol trisphosphate receptor. J Biol Chem. 263:1988;1530-1534.
4. Mignery G. A., Südhof T. C., Takei K., De Camilli P. Putative receptor for inositol 1,4,5-trisphosphate similar to ryanodine receptor. Nature. 342:1989;192-195.
5. 400. Nature. 342:1989;32-38.
6. Ferris C. D., Huganir R. L., Supattapone S., Snyder S. H. Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles. Nature. 342:1989;87-89.
7. 2+release in rat cerebellar Purkinje neurones. J Physiol. 487:1995;343-358.
8. 3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature. 351:1991;751-754.
9. 3receptor subtypes. EMBO J. 18:1999;1303-1308.
10. Oberdorf J., Webster J. M., Zhu C. C., Wojcikiewicz R. J. Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway. Biochem J. 339:1999;453-461.
11. Sugawara H., Kurosaki M., Takata M., Kurosaki T. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J. 16:1997;3078-3088.
12. 2+channels. Biochim Biophys Acta. 1436:1998;19-33.
13. 2+safeguards against spontaneous activity. Curr Biol. 7:1997;510-518.
14. Patel S., Joseph S. K., Thomas A. P. Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium. 25:1999;247-264.
15. 2+release of separate quanta. Pflügers Archiv. 437:1999;691-694.
16. 2+. Biochem J. 328:1997;785-793.
17. 2+differentially regulates ligand-affinity states of type 1 and 3 inositol 1,4,5-trisphosphate receptors. Biochem J. 322:1997;591-596.
18. 3receptor channel stays open in the presence of increased calcium. Nature. 296:1998;81-84.
19. 3R) expressed in Xenopus oocytes by nuclear patch clamping. Biophys J. 76:1999;A375.
20. 3receptor in 16HBE14o- bronchial mucosal cells. J Biol Chem. 273:1998;8983-8986.
21. 2+mobilization. Biochem J. 344:1999;55-60.
22. 2+binding site in the type I inositol 1,4,5-trisphosphate receptor. J Biol Chem. 271:1996;27005-27012.
23. 2+. Curr Biol. 9:1999;1115-1118.
24. Berridge M. J. Elementary and global aspects of calcium signalling. J Physiol. 499.2:1997;291-306.
25. Hajnóczky G., Thomas A. P. The inositol trisphosphate calcium channel is inactivated by inositol trisphosphate. Nature. 370:1994;474-477.
26. 2+mobilization. EMBO J. 15:1996;2086-2093.
27. Marchant J. S., Taylor C. W. Rapid activation and partial inactivation of inositol trisphosphate receptors by inositol trisphosphate. Biochemistry. 37:1998;11524-11533.
28. Katayama E., Funashashi H., Michikawa T. Native structure and arrangement of inositol-1,4,5-trisphosphate receptor molecules in bovine cerebellar Purkinje cells as studied by quick-freeze deep-etch electron microscopy. EMBO J. 15:1996;4844-4851.
29. Mignery G. A., Südhof T. C. The ligand binding site and transduction mechanism in the inositol-1,4,5-trisphosphate receptor. EMBO J. 9:1990;3893-3898.
30. Joseph S. K., Pierson S., Samanta S. Trypsin digestion of the inositol trisphosphate receptor: implications for the conformation and domain organization of the protein. Biochem J. 307:1995;859-865.
31. 2+and calmodulin. J Biol Chem. 274:1999;12157-12162.
32. Yoshikawa F., Iwasaki H., Michikawa T., Furuichi T., Mikoshiba K. Cooperative formation of the ligand-binding site of the inositol 1,4,5-trisphosphate receptor by two separable domains. J Biol Chem. 274:1999;328-334.
33. Mignery G. A., Newton C. L., Archer B. T., Südhof T. C. Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. J Biol Chem. 265:1990;12679-12685.
34. Joseph S. K., Boehning D., Pierson S., Nicchitta C. V. Membrane insertion, glycosylation, and oligomerization of inositol trisphosphate receptors in a cell-free translation system. J Biol Chem. 272:1997;1579-1588.
35. Balshaw D., Gao L., Meissner G. Luminal loop of the ryanodine receptor: A pore-forming segment? Proc Natl Acad Sci USA. 96:1999;3345-3347.
36. Ramos-Franco J., Galvan D., Mignery G. A., Fill M. Location of the permeation pathway in the recombinant type-1 inositol 1,4,5-trisphosphate receptor. J Gen Physiol. 114:1999;243-250.
37. Berridge M. J., Irvine R. F. Inositol phosphates and cell signalling. Nature. 341:1989;197-205.
38. 2+signaling. Curr Op Neurobiol. 7:1997;339-345.
39. Wilcox R. A., Primrose W. U., Nahorski S. R., Challiss R. A. J. New developments in the molecular pharmacology of the myo -inositol 1,4,5-trisphosphate receptor. Trends Pharmacol Sci. 19:1998;467-475.
40. Striggow F., Ehrlich B. E. Ligand-gated ion channels inside and out. Curr Op Cell Biol. 8:1996;490-495.
41. 2+-release channel function. Biochem J. 337:1999;345-361.
42. 3receptor. EMBO J. 10:1991;3199-3206.
43. Blondel O., Takeda J., Janssen H., Seino S., Bell G. I. Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J Biol Chem. 268:1993;11356-11363.
44. Yamamoto-Hino M., Sugiyama T., Hikichi K., Mattei M. G., Hasegawa K., Sekine S., Sakurada K., Miyawaki A., Furuichi T., Hasegawa M., Mikoshiba K. Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. Recept Channel. 2:1994;9-22.
45. 3R1: structure, function, regulation of expression and chromosomal localization. Biochem J. 302:1994;781-790.
46. Ross C. A., Danoff S. K., Schell M. J., Snyder S. H., Ullrich A. Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proc Natl Acad Sci USA. 89:1992;4265-4269.
47. De Smedt H., Missiaen L., Parys J. B. Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. Biochem J. 322:1997;575-583.
48. 3receptor: structure, function and localization in oocytes and eggs. Cell. 75:1993;555-570.
49. Yoshikawa S., Tanimura T., Miyawaki A. Molecular cloning of and characterization of the inositol 1,4,5-trisphosphate receptor in Drosophila melanogaster. J Biol Chem. 267:1992;16613-16619.
50. Wilson R., Ainscough R., Anderson K. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature. 368:1994;32-38.
51. Kamikouchi A., Takeuchi H., Sawata M., Ohashi K., Natori S., Kubo T. Preferential expression of the gene for a putative inositol 1,4,5-trisphosphate receptor homologue in the mushroom bodies of the brain of the worker honeybee Apis mellifera L. Biochem Biophys Res Commun. 242:1998;181-186.
52. Yoshikawa F., Morita M., Monkawa T., Michikawa T., Furuichi T., Mikoshiba K. Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. J Biol Chem. 271:1996;18277-18284.
53. Sayers L. G., Miyawaki A., Muto A. Intracellular targeting and homotetramer formation of a truncated inositol 1,4,5-trisphosphate-green fluorescent protein chimera in Xenopus laevis oocytes: evidence for the involvement of transmembrane spanning domain in endoplasmic reticulum targeting and homotetramer formation. Biochem J. 323:1997;273-280.
54. Furutama D., Shimoda K., Yoshikawa S., Miyawaki A., Furuichi T., Mikoshiba K. Functional expression of the type 1 inositol 1,4,5-trisphosphate receptor promoter- lacz fusion genes in transgenic mice. J Neurochem. 66:1996;1793-1801.
55. 1MF-2 smooth muscle cells. Cell Calcium. 23:1998;11-21.
56. Deelman L. E., Jonk L. J., Henning R. H. The isolation and characterization of the promoter of the human type 1 inositol 1,4,5-trisphosphate receptor. Gene. 207:1998;219-225.
57. Kirkwood K. L., Homick K., Dragon M. B., Bradford P. G. Cloning and characterization of the type I inositol 1,4,5-trisphosphate receptor gene promoter. Regulation by 17beta-estradiol in osteoblasts. J Biol Chem. 272:1997;22425-22431.
58. Morikawa K., Ohbayashi T., Nakagawa M. Transcription initiation sites and promoter structure of the mouse type 2 inositol 1,4,5-trisphosphate receptor gene. Gene. 196:1997;181-185.
59. Sinha M., Hasan G. Sequencing and exon mapping of the inositol 1,4,5-trisphosphate receptor cDNA from drosophila embryos suggests the presence of differentially regulated forms of RNA and protein. Gene. 233:1999;271-276.
60. Nakagawa T., Okano H., Furuichi T., Aruga J., Mikoshiba K. The subtypes of the mouse inositol 1,4,5-trisphosphate receptor are expressed in tissue-specific and developmentally specific manner. Proc Natl Acad Sci USA. 88:1991;6244-6248.
61. Danoff S. K., Ferris C. D., Donath C. Inositol 1,4,5-trisphosphate receptors: distinct neuronal and nonneuronal forms derived by alternative splicing differ in phosphorylation. Proc Natl Acad Sci USA. 88:1991;2951-2955.
62. Nucifora F. C., Li S-H., Danoff S., Ullrich A., Ross C. A. Molecular cloning of a cDNA for the human inositol 1,4,5-trisphosphate receptor type 1, and the identification of a third alternatively spliced variant. Mol Brain Res. 32:1995;291-296.
63. 3receptor. Biochem J. 334:1998;559-563.
64. De Smedt H., Missiaen L., Parys J. B. Determination of the relative amounts of inositol trisphosphate receptor mRNA isoforms by ratio polymerase chain reaction. J Biol Chem. 269:1994;21691-21698.
65. Wojcikiewicz R. J. H. Type I,II and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. J Biol Chem. 270:1995;11678-11683.
66. 2+-ATPase and inositol 1,4,5-trisphosphate receptor isoforms in vascular endothelial cells. Cell Calcium. 25:1999;371-380.
67. Bush K., Sturat R. O., Li S-H. Epithelial inostiol 1,4,5-trisphosphate receptors. Multiplicity of localization, solubility, and isoforms. J Biol Chem. 38:1994;23694-23699.
68. Pozzan T., Rizzuto R., Volpe P., Meldolesi J. Molecular and cellular physiology of intracellular calcium stores. Physiol Rev. 74:1994;595-636.
69. Takei K., Mignery G. A., Mugnaini E., Südhof T. C., De Camilli P. Inositol 1,4,5-trisphosphate receptor causes formation of ER cisternal stacks in transfected fibroblasts and in cerebellar Purkinje cells. Neuron. 12:1994;327-342.
70. 3receptor channels. Cell. 14:1995;163-167.
71. 3) receptors inXenopus oocyte nucleus. J Gen Physiol. 109:1997;571-587.
72. 2+store, with functional properties distinct from those of the endoplasmic reticulum. EMBO J. 17:1998;5298-5308.
73. Yule D. I., Ernst S. A., Ohnishi H., Wojcikiewicz R. J. H. Evidence that zymogen granules are not a physiologically relevant calcium pool. Defining the distribution of inositol 1,4,5-trisphosphate receptors in pancreatic acinar cells. J Biol Chem. 272:1997;9093-9098.
74. Nucifora F. C., Sharp A. H., Milgram S. L., Ross C. A. Inositol 1,4,5-trisphosphate receptors in endocrine cells: localization and association in hetero- and homotetramers. Mol Biol Cell. 7:1996;949-960.
75. Ravazzola M., Halban P. A., Orci L. Inositol 1,4,5-trisphosphate receptor subtype 3 in pancreatic islet cell secretory granules revisited. Proc Natl Acad Sci USA. 93:1996;2745-2748.
76. 2+from single isolated pancreatic zymogen granules. Cell. 84:1996;473-480.
77. 2+store in secretory granules of insulin-producing cells. J Biol Chem. 269:1994;27167-27170.
78. Kuno M., Gardner P. Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature. 326:1987;301-304.
79. Khan A. A., Soloski M. J., Sharp A. H. Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science. 273:1996;503-507.
80. Khan A. A., Steiner J. P., Snyder S. H. Plasma membrane inositol 1,4,5-trisphosphate receptor of lymphocytes: selective enrichment in sialic acid and unique binding specificity. Proc Natl Acad Sci USA. 89:1992;2849-2853.
81. Putney J. W. Jr. Type 3 inositol 1,4,5-trisphosphate receptor and capacitative calcium entry. Cell Calcium. 21:1997;257-261.
82. Fujimoto T., Nakade S., Miyawaki A., Mikoshiba K., Ogawa K. Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol. 119:1992;1507-1513.
83. 2+stores in sarcoplasmic and endoplasmic reticulum. Science. 275:1997;1643-1648.
84. 2+] subcompartments in intact HeLa cells. J Cell Biol. 139:1997;601-611.
85. 2+channels in pancreatic and salivary gland cells. J Biol Chem. 272:1997;15765-15770.
86. Zhang X., Wen J., Bidasee K. R. Ryanodine and inositol trisphosphate receptors are differentially distributed and expressed in rat parotid gland. Biochem J. 340:1999;519-527.
87. 2+initiation site of ductal epithelium of submandibular gland. J Cell Biol. 141:1998;135-142.
88. 2+responses. Science. 280:1998;1763-1766.
89. Lipp P., Thomas D., Berridge M. J., Bootman M. D. Nuclear calcium signalling by individual cytoplasmic calcium puffs. EMBO J. 16:1997;7166-7173.
90. 3receptors and store-operated Htrp3 channels. Nature. 396:1998;478-482.
91. Joseph S. K., Lin C., Pierson S., Thomas A. P., Maranto A. R. Heteroligomers of type-I and type-III inositol trisphosphate receptors in WB rat liver epithelial cells. J Biol Chem. 270:1995;23310-23315.
92. Wojcikiewicz R. J. H., He Y. Type I, II and III inositol 1,4,5-trisphosphate receptor co-immunoprecipitation as evidence for the existence heterotetrameric receptor complexes. Biochem Biophys Res Commun. 213:1995;334-341.
93. Monkawa T., Miyawaki A., Sugiyama T. Heterotetrameric complex formation of of inositol 1,4,5-trisphosphate receptor subunits. J Biol Chem. 270:1995;14700-14704.
94. Wilson B. S., Pfeiffer J. R., Smith A. J., Oliver J. M., Oberdorf J. A., Wojcikiewicz R. J. H. Calcium-dependent clustering of inositol 1,4,5-trisphosphate receptors. Mol Biol Cell. 9:1998;1465-1478.
95. Fischer G. A., Clementi E., Raichman M., Südhof T., Ullrich A., Meldolesi J. Stable expression of truncated inositol 1,4,5-trisphosphate receptor subunits in 3T3 fibroblasts. J Biol Chem. 269:1994;19216-19224.
96. Zhu C. C., Furuichi T., Mikoshiba K., Wojcikiewicz R. J. Inositol 1,4,5-trisphosphate receptor down-regulation is activated directly by inositol 1,4,5-trisphosphate binding. Studies with binding-defective mutant receptors. J Biol Chem. 274:1999;3476-3484.
97. Wojcikiewicz R. J. H., Luo S. G. Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase. J Biol Chem. 273:1998;5670-5677.
98. Joseph S. K., Ryan S. V. Phosphorylation of the inositol trisphosphate receptor in isolated rat hepatocytes. J Biol Chem. 268:1993;23059-23065.
99. Böhm S. K., Grady E. F., Bunnett N. W. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J. 322:1997;1-18.
100. Bradford P. G., Wang X., Jin Y., Hui P. Transcriptional regulation and increased functional expression of the inositol trisphosphate receptor in retinoic acid-treated HL-60 cells. J Biol Chem. 267:1992;20959-20964.
101. Bradford P. G., Autier M. Increased expression of the inositol 1,4,5-trisphosphate receptor in human leukaemic (HL-60) cells differentiated with retinoic acid or dimethyl sulphoxide. Biochem J. 280:1991;205-210.
102. Bradford P. G., Jin Y., Hui P. 1,25-dihydroxyvitamin D3 enhances the transcription and expression of the inositol trisphosphate receptor gene in HL-60 cells. Mol Pharmacol. 44:1993;292-297.
103. Matsumoto M., Nakagawa T., Inoue T. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature. 379:1996;168-171.
104. Inoue T., Kato K., Kohda K., Mikoshiba K. Type 1 inositol 1,4,5-trisphosphate receptor is required for induction of long-term depression in cerebellar Purkinje neurons. J Neurosci. 18:1998;5366-5373.
105. Genazzani A. A., Carafoli E., Guernini D. Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons. Proc Natl Acad Sci USA. 96:1999;5797-5801.
106. Yakel J. L. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci. 18:1997;124-134.
107. Klee C. B., Ren H., Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 273:1998;13367-13370.
108. Snyder S. H., Sabatini D. M., Lai M. M., Steiner J. P., Hamilton G. S., Suzdak P. D. Neural actions of immunophilin ligands. Trends Pharmacol Sci. 19:1998;21-26.
109. Rao A., Luo C., Hogan P. G. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 15:1997;707-747.
110. Ho A. M., Jain J., Rao A., Hogan P. G. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J Biol Chem. 269:1994;28181-28186.
111. Konishi Y., Kobayashi Y., Kishimoto T. Demonstration of an E-box and its CNS-related binding factors for transcriptional regulation of the mouse type 1 inositol 1,4,5-trisphosphate receptor gene. J Neurochem. 69:1997;476-484.
112. Konishi Y., Ohkawa N., Makino Y. Transcriptional regulation of mouse type 1 inositol 1,4,5-trisphosphate receptor gene by Neuro D-related factor. J Neurochem. 72:1999;1717-1724.
113. Ohkawa N., Konishi Y., Shimada M. Activation of the mouse inositol 1,4,5-trisphosphate receptor type 1 promoter by AP-2. Gene. 229:1999;11-19.
114. Day D. A., Tuite M. F. Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. J Endocrinol. 157:1998;361-371.
115. Ross J. Control of messenger RNA stability in higher eukaryotes. Trends Genet. 12:1996;171-175.
116. Chen C. Y., Shyu A. B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci. 20:1995;465-470.
117. Wojcikiewicz R. J., Ernst S. A., Yule D. I. Secretagogues cause ubiquitination and down-regulation of inositol 1,4,5-trisphosphate receptors in rat pancreatic acinar cells. Gastroenterol. 116:1999;1194-1201.
118. 2+mobilization and inositol 1,4,5-trisphosphate binding. J Biol Chem. 266:1991;22234-22241.
119. Wojcikiewicz R. J. H., Nakade S., Mikoshiba K., Nahorski S. R. Inositol 1,4,5-trisphosphate receptor immunoreactivity in SH-SY5Y human neuroblastoma cells is reduced by chronic muscarinic receptor activation. J Neurochem. 59:1992;383-386.
120. Wojcikiewicz R. J. H., Furuichi T., Nakade S., Mikoshiba K., Nahorski S. R. Muscarinic receptor activation down-regulates the type 1 inositol 1,4,5-trisphosphate receptor by accelerating its degradation. J Biol Chem. 269:1994;7963-7969.
121. Bokkala S., Joseph S. K. Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells. Evidence for involvement of the proteasome pathway. J Biol Chem. 272:1997;12454-12461.
122. 2+mobilization. Mol Pharmacol. 50:1996;493-500.
123. Wojcikiewicz R. J. H., Oberdorf J. A. Degradation of inositol 1,4,5-trisphosphate receptors during cell stimulation is a specific process mediated by a cysteine protease activity. J Biol Chem. 271:1996;16652-16655.
124. Putney, J. W. Jr, Capacitative calcium entry, Austin, USA, R.G.Landes Company, 1997.
125. 2+stores to inositol 1,4,5-trisphosphate. Mol Pharmacol. 41:1992;115-119.
126. Hershko A., Ciechanover A. The ubiquitin system. Annu Rev Biochem. 67:1998;425-479.
127. Plemper R. K., Wolf D. H. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem Sci. 24:1999;266-270.
128. Hiller M. M., Finger A., Schweiger M., Wolf D. H. ER degradation of misfolded luminal protein by the cytosolic ubiquitin-protease pathway. Science. 273:1996;1725-1728.
129. Lee B., Bradford P. G., Laychock S. G. Characterization of inositol 1,4,5-trisphosphate receptor isoform mRNA expression and regulation in rat pancreatic islets, RINm5F clls and βHC9 cells. J Mol Endocrinol. 21:1998;31-39.
130. 3receptor in human myometrial smooth muscle. Pflügers Archiv. 431:1996;697-705.
131. 2+signals in bronchial epithelial cells. Pflügers Archiv. 436:1998;40-48.
132. Maeda N., Kawasaki T., Nakade S. Structural and functional characterization of inositol 1,4,5-trisphosphate receptor channel from mouse cerebellum. J Biol Chem. 266:1991;1109-1116.
133. Wojcikiewicz R. J. H., Luo S. G. Differences among type I, II, and III inositol-1,4,5-trisphosphate receptors in ligand-binding affinity influence the sensitivity of calcium stores to inositol-1,4,5-trisphosphate. Mol Pharmacol. 53:1998;656-662.
134. Parrington J., Brind S., De Smedt H. Expression of inositol 1,4,5-trisphosphate receptors in mouse oocytes and early embryos: the type I isoform is upregulated in oocytes and downregulated after fertilization. Dev Biol. 203:1998;451-461.
135. Rosemblit N., Moschella M. C., Ondriasa E., Gutstein D. E., Ondrias K., Marks A. R. Intracellular calcium release channel expression during embryogenesis. Dev Biol. 206:1999;163-177.
136. Tasker P. N., Michelangeli F., Nixon G. F. Expression and distribution of the type 1 and type 3 inositol 1,4,5-trisphosphate receptor in developing vascular smooth muscle. Circ Res. 84:1999;536-542.
137. Sugiyama T., Yamamoto-Hino M., Miyawaki A., Furuichi T., Mikoshiba K., Hasegawa M. Subtypes of inositol 1,4,5-trisphosphate receptor in human hematopoietic cell lines: dynamic aspects of their cell-type specific expression. FEBS Lett. 349:1994;191-196.
138. Sharma K., Wang L. W., Zhu Y. Q., DeGuzman A., Cao G. Y., Joseph S. K. Renal type 1 inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice. Am J Physiol. 45:1999;F54-F61.
139. Go L. O., Moschella M. C., Watras J., Handa K. K., Fyfe B. S., Marks A. R. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest. 95:1995;888-894.
140. Simpson P. B., Challiss R. A., Nahorski S. R. Chronic activation of muscarinic and metabotropic glutamate receptors down-regulates type I inositol 1,4,5-trisphosphate receptor expression in cerebellar granule cells. J Neurochem. 63:1994;2369-2372.
141. Honda Z., Takano T., Hirose N. Gq pathway desensitizes chemotactic receptor-induced calcium signaling via inositol trisphosphate receptor down-regulation. J Biol Chem. 270:1995;4840-4844.
142. Lee B., Jonas J-C., Weir G. C., Laychock S. G. Glucose regulates expression of inositol 1,4,5-trisphosphate receptor isoforms in isolated rat pancreatic islets. Endocrinol. 140:1999;2173-2182.
143. Sharma K., Wang L., Zhu Y., Bokkala S., Joseph S. K. Transforming growth factor-betal inhibits type I inositol 1,4,5-trisphosphate receptor expression and enhances its phosphorylation in mesangial cells. J Biol Chem. 272:1997;14617-14623.
144. Galvan D. L., Borrego-Diaz E., Perez P. J., Mignery G. A. Subunit oligomerization, and topology of the inositol 1,4,5-trisphosphate receptor. J Biol Chem. 274:1999;29483-29492.
145. Graef I. A., Mermelstein P. G., Stankunas K. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurones. Nature. 401:1999;703-708.